Eutilex, Russian Divisional Patent Related to 4-1BB Antibody Therapy

by Hwang Junho

Published 03 Aug.2022 11:12(KST)

[Asia Economy Reporter Junho Hwang] Eutilex announced on the 3rd that it has additionally secured a Russian patent for "Antibody and its fragment having structural features not found in anti-human 4-1BB antibodies" related to the split patent of the 4-1BB antibody therapeutic 'EU101'. This patent includes technical features such as improved binding affinity and induction of killer T cell proliferation compared to existing anti-4-1BB antibodies without structural characteristics.